E
RAMM Pharma Corp. RAMM
CNSX
Recommendation
Sell
Prev Close
$0.04
Volume
--
Avg Vol (90D)
35,787
Market Cap
$3.51M
Dividend & Yield
--
52-Week Range
$0.015 - $0.105
P/E (TTM)
--
EPS (TTM)
-$0.0516
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$3.48M
EBITDA (TTM)
-$4.27M
EBIT (TTM)
-$5.05M
Net Income (TTM)
-$6.18M
Balance Sheet
Total Assets (Q)
$22.65M
Total Debt (Q)
$263.30K
Total Liabilities (Q)
$1.91M
Book Value Per Share (Q)
$0.1737
Cash Flow
Cash from Operations (TTM)
-$3.30M
Cash from Investing (TTM)
$84.00K
Cash from Financing (TTM)
-$241.40K
Net Change in Cash (TTM)
-$3.46M
Filings
Filing Date
Friday, March 29, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of Jun 24 and 28 (est)
Price History
Loading...
Beta
0.52
7-Day Total Return
0.00%
30-Day Total Return
-33.33%
60-Day Total Return
14.29%
90-Day Total Return
-27.27%
Year to Date Total Return
-27.27%
1-Year Total Return
-38.46%
2-Year Total Return
-80.95%
3-Year Total Return
-95.29%
5-Year Total Return
--
52-week Low
Dec 20, 2023 - $0.015
52-week High
Sep 08, 2023 - $0.105
Valuation
Market Cap
$3.51M - Nano Cap
Enterprise Value
$906.67K
Price/Sales (TTM)
1.37
Price/Book (Q)
0.23
Dividends and Shares
Shares Outstanding
119.39M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
--
Phone Number
416-848-7744
Address
200, 82 Richmond St. East
Toronto, ON M5C 1P1
Country
Canada
Year Founded
1987
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmacology and formulations, pharmaceuticals, cosmetics, and nutraceutical products in Uruguay... more
Weiss Ratings